| Patent application number | Description | Published |
|---|
| 20080260770 | Use of Tellurium Compounds as Adjuvants - Methods for enhancing the immune response of a subject to an immunoeffector, and methods of enhancing interleukin-12 production, which are effected by administering an amount of the immunoeffector and an effective adjuvanting amount of a tellurium-containing compound are provided. The enhanced immune response may be a cell-mediated or a humoral immune response. A pharmaceutical composition, which comprises the tellurium-containing compound, the immunoeffector and a pharmaceutically acceptable carrier is also provided. Use of a tellurium-containing compound as an adjuvant for immunization is also provided. | 10-23-2008 |
| 20090054391 | Biologically active complex - The invention relates to an aqueous solution containing at least one species selected from the group consisting of a 1:1 molar complex of TeO | 02-26-2009 |
| 20090269289 | Use of Tellurium Compounds for Protection from Ultra-Violet Radiation - Methods for treating skin conditions such as basal cell carcinoma and/or actinic keratosis are provided, which are effected by administering a pharmaceutically effective amount of a tellurium-containing compound. A pharmaceutical composition for treatment of skin conditions such as basal cell carcinoma an/or actinic keratosis is also provided. | 10-29-2009 |
| 20090269418 | Compositions and Methods for Inducing Hair Growth - Novel therapeutic methods and pharmaceutical compositions utilizing tellurium-containing compounds for inducing hair growth for the treatment of various types of alopecia and other conditions associated with hair loss. | 10-29-2009 |
| 20100055055 | TOPICAL FORMULATIONS OF TELLURIUM-CONTAINING COMPOUNDS - Novel formulations of tellurium-containing compounds, which are suitable for topical application, are disclosed. The formulations are characterized by high chemical and physical stability and are easy to handle and use. | 03-04-2010 |
| 20100062081 | Use of tellurium containing compounds as nerve protecting agents - A novel neuroprotective agent is disclosed for the treatment and prevention of neurodegenerative disorders which is based on the administration of an effective amount of a tellurium compound which has a specific ability to induce the differentiation and interfere with apoptotic cell death pathways of neuronal PC-12 cells. | 03-11-2010 |
| 20100081623 | NOVEL TELLURIUM COMPOUNDS AND THEIR USE AS IMMUNOMODULATORS - Novel tellurium-containing compounds and uses thereof as immunomodulators are disclosed. | 04-01-2010 |
| 20100087521 | BIOLOGICALLY ACTIVE COMPLEX - The invention relates to an aqueous solution containing at least one species selected from the group consisting of a 1:1 molar complex of TeO | 04-08-2010 |
| 20100150869 | USE OF TELLURIUM COMPOUNDS FOR TREATMENT OF BASAL CELL CARCINOMA AND/OR ACTINIC KERATOSIS - Methods for treating skin conditions such as basal cell carcinoma and/or actinic keratosis are provided, which are effected by administering a pharmaceutically effective amount of a tellurium-containing compound. A pharmaceutical composition for treatment of skin conditions such as basal cell carcinoma an/or actinic keratosis is also provided. | 06-17-2010 |
| 20100233294 | USE OF TELLURIUM COMPOUNDS FOR INHIBITION OF INTERLEUKIN-CONVERTING ENZYME - Use of tellurium-containing compounds for treating conditions in which inhibition of caspase-1/interleuFkin-1β enzyme (ICE) is beneficial is disclosed. | 09-16-2010 |
| 20100297256 | METHODS AND COMPOSITIONS FOR INHIBITING INTEGRINS USING TELLURIUM-CONTAINING COMPOUNDS - Compositions and methods for inhibiting integrin and treating integrin-related conditions, utilizing tellurium-containing compounds, are disclosed. The tellurium-containing compounds comprise at least one tellurium dioxo moiety and may have any one of Formulae I to IV as defined in the specification. Further disclosed are compositions and methods for treating a neoplastic condition characterized by a resistance to an anti-neoplastic agent and by a high level of expression of an integrin by neoplastic cells. | 11-25-2010 |
| 20100330201 | Therapeutic methods and pharmaceutical compositions for treating warts with tellurium compounds - A novel method for treating skin and mucosal membrane ailments caused by human papilloma viruses, which utilizes tellurium-containing compounds, is disclosed. Also disclosed are pharmaceutical compositions containing tellurium-containing compounds for treating such ailments. | 12-30-2010 |
